SEI Investments’s Palvella Therapeutics PVLA Stock Holding History

SEI Investments’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Sell	12,807 -3,856	-23%	-$468K	﹤0.01%	1966
2026 Q1	$2.08M	Buy	16,663 +4,944	+42%	+$516K	﹤0.01%	1988
2025 Q4	$1.23M	Buy	+11,719	New	+$1,000K	﹤0.01%	2090
2018 Q3	–	Hold	0	–	–	–	3506
2018 Q2	–	Hold	0	–	–	–	3823
2018 Q1	–	Hold	0	–	–	–	3697
2017 Q4	–	Sell	-6	Closed	-$2.79K	–	3522
2017 Q3	$3K	Buy	+6	New	+$2.56K	﹤0.01%	2944

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

SEI Investments's PVLA Position: Q2 2026 in Review

SEI Investments reduced its Palvella Therapeutics (PVLA) stake by 23% in Q2 2026, selling an estimated $468K and leaving 12,807 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

SEI Investments first reported a position in PVLA in Q3 2017 and has held it in 4 quarters since. The position peaked at $2.08M in Q1 2026. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

SEI Investments held 12,807 shares of Palvella Therapeutics worth $1.96M as of Q2 2026.
SEI Investments sold 3,856 Palvella Therapeutics shares in Q2 2026, an estimated $468K.
Palvella Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1966 holding.
SEI Investments first reported a position in Palvella Therapeutics in Q3 2017 and has held it in 4 quarters since.
SEI Investments's Palvella Therapeutics position peaked at $2.08M in Q1 2026.
197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.